Oppenheimer analyst Shaul Eyal commented on Nuance Communications (NASDAQ: NUAN) after the company adopted a poison pill Tuesday.

"Ultimately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE